Epidemiological profile of snakebites cases recorded at the 3rd military hospital laayoune morocco between 2011 and 2017 Badr Adouani1,*, Abderrahman Elwali1,2, Hassan Alaoui3, Mina Ait Elcadi4, Rachid Eljaoudi4, Yassir Bousliman4 13rd Military Hospital Laayoune, Morocco 2 Sidi Mohamed Ben Abdellah University, Faculty of Medicine and Pharmacy, Fez, Morocco 3Avicenna Military Hospital, Marrakech, Morocco 4 Mohammed V University, Faculty of Medicine and Pharmacy, Laboratory of Pharmacology and Toxicology, Rabat, Morocco *Corresponding Author E-mail: badradouaniph@gmail.com
Online published on 21 August, 2018. Abstract Snake bites pose a major public health problem worldwide, this pathology is worrying given the mortality, the morbidity it causes and the limited and often discontinuous availability of antivenomserotherapy. The objective of our study is to reveal the epidemiological characteristics, and the elements of management of Ophidian envenomations in the region of Laayoune in Morocco and to follow the practice of an Inoserp® MENA antigen after the production stop of FAVafrique®. This is a retrospective and descriptive study of a series of 23 viperin bite-related cases, which were admitted between January 2011 and December 2017 at the 3rd Military Hospital Laayoune in Morocco. The analysis of inpatient records allowed us to study the circumstances of bite occurrence according to the climatic conditions of the area, biological data, clinical signs, severity criteria and therapeutic treatment. The length of stay in the hospital allowed us to compare two groups; it was lower in the group of patients who received Inoserp®, compared to the group of patients who received the FavAfrique®. This reduction in the length of stay in the intensive care unit, which implies a decrease in the use of other therapies, associated biological and radiological assessments, has saved approximately $ 125 per patient. The availability of antivenoms in first aid units and early management has improved the prognosis. Top Keywords Snake bite, FAVafrique®, Inoserp® MENA, envenomation, Morocco. Top |